» Articles » PMID: 28603718

Impact of Sleep Apnea on In-hospital Outcomes After Transcatheter Aortic Valve Replacement: Insight from National Inpatient Sample Database 2011-2014

Overview
Journal Ann Transl Med
Date 2017 Jun 13
PMID 28603718
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sleep apnea is associated with worse outcomes following various kinds of surgeries. There is a paucity of data on the association of sleep apnea with clinical outcomes after transcatheter aortic valve replacement (TAVR).

Methods: We used National Inpatient Sample (NIS) data 2011-2014 to identify patients undergoing TAVR. Association between sleep apnea and in-hospital postoperative outcomes were assessed by multivariate logistic regression and 1:1 propensity score matching analyses.

Results: Of 42,189 patients who received TAVR, 4,605 patients (10.9%) had sleep apnea. Patients with sleep apnea were more likely to be younger and male with higher prevalences of hypertension, diabetes mellitus, dyslipidemia, chronic kidney disease, pulmonary hypertension and obesity who less frequently received transapical access than those without sleep apnea. The group with sleep apnea had less bleeding requiring transfusion (8.6% 11.9%, P=0.01) than the counterpart. After adjusting for confounders, the presence of sleep apnea was no longer independently associated with any of the studied outcomes including all-cause mortality (OR 0.95; 95% CI: 0.64-1.42), stroke (OR 1.08; 95% CI: 0.65-1.81), myocardial infarction (OR 0.66; 95% CI: 0.36-1.22), acute respiratory failure (OR 0.94; 95% CI: 0.72-1.23), pneumothorax (OR 0.64; 95% CI: 0.26-1.59), vascular complication (OR 0.91; 95% CI: 0.69-1.22), bleeding requiring transfusion (OR 0.85; 95% CI: 0.65-1.11), acute kidney injury requiring hemodialysis (OR 0.94; 95% CI: 0.53-1.66) and permanent pacemaker implantation (OR 1.12; 95% CI: 0.87-1.43). The length and cost of hospital stay were not affected by sleep apnea, either.

Conclusions: With a prevalence of 10.9%, the presence of sleep apnea was not independently associated with postoperative in-hospital outcomes in patients undergoing TAVR in NIS data 2011 to 2014.

Citing Articles

Bidirectional association of sleep disorders with chronic kidney disease: a systematic review and meta-analysis.

Koh J, Lim C, Yam K, Yeo B, Ng A, Loh S Clin Kidney J. 2024; 17(11):sfae279.

PMID: 39525685 PMC: 11549560. DOI: 10.1093/ckj/sfae279.


Impact of Obstructive Sleep Apnea Diagnosed Using the STOP-Bang Questionnaire Scale on Postoperative Complications Following Major Cardiac Surgery: A Prospective Observational Cohort Study.

Javaherforooshzadeh F, Amjadzadeh M, Haybar H, Sharafkhaneh A Cureus. 2022; 14(6):e26102.

PMID: 35875276 PMC: 9297118. DOI: 10.7759/cureus.26102.

References
1.
Memtsoudis S, Stundner O, Rasul R, Chiu Y, Sun X, Ramachandran S . The impact of sleep apnea on postoperative utilization of resources and adverse outcomes. Anesth Analg. 2014; 118(2):407-418. PMC: 4120109. DOI: 10.1213/ANE.0000000000000051. View

2.
Smith C, Leon M, Mack M, Miller D, Moses J, Svensson L . Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23):2187-98. DOI: 10.1056/NEJMoa1103510. View

3.
Nicholl D, Ahmed S, Loewen A, Hemmelgarn B, Sola D, Beecroft J . Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia. Chest. 2012; 141(6):1422-1430. DOI: 10.1378/chest.11-1809. View

4.
Vahanian A, Alfieri O, Andreotti F, Antunes M, Baron-Esquivias G, Baumgartner H . Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012; 42(4):S1-44. DOI: 10.1093/ejcts/ezs455. View

5.
Buchanan G, Chieffo A, Montorfano M, Maisano F, Latib A, Godino C . The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry. EuroIntervention. 2011; 7(5):556-63. DOI: 10.4244/EIJV7I5A91. View